Analysis of human neuropeptide FF gene expression

Journal of Neurochemistry

Volumn 82, Issue 6, 2002, Pages 1330-1342

  Nystedt, Johanna M ^a,d   Brandt, Annika M ^a   Mandelin, Jami ^d   Vilim, Ferdinand S ^b   Ziff, Edward B ^c   Panula, Pertti ^a,d  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antiopioid; Neuropeptide; NPFF; PC12; Promoter; RF amide

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROPEPTIDE FF; OPIATE ANTAGONIST; POLYADENYLATED RNA;

ARTICLE; CELL STRAIN; GENE ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MEDULLA OBLONGATA; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SILENCER GENE; SPINAL CORD; TRANSCRIPTION INITIATION;

3' UNTRANSLATED REGIONS; 5' FLANKING REGION; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CLONING, MOLECULAR; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; OLIGOPEPTIDES; PC12 CELLS; PROMOTER REGIONS (GENETICS); RATS; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; TRANSCRIPTION INITIATION SITE; TRANSFECTION; TUMOR CELLS, CULTURED;

EUKARYOTA;

EID: 0036734776     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01035.x     Document Type: Article

References (60)

1. Aarnisalo A. A., Tuominen R. K., Nieminen M., Vainio P. and Panula P. (1997) Evidence for prolactin releasing activity of neuropeptide FF in rats. Neuroendocrinol. Lett. 18, 191-196.
2. Allen J. M., Martin J. B. and Heinrich G. (1987) Neuropeptide Y gene expression in PC12 cells and its regulation by nerve growth factor: a model for developmental regulation. Brain Res. 427, 39-43.
3. Altschul S. F., Gish W., Miller W., Myers E. W. and Lipman D. J. (1990) Basic local alignment search tool. J. Mol. Biol. 215, 403-410.
4. Askwith C. C., Cheng C., Ikuma M., Benson C., Price M. P. and Welsh M. J. (2000) Neuropeptide FF and FMRFamide potentiate acidevoked currents from sensory neurons and proton-gated DEG/ENaC channels. Neuron 26, 133-141.
5. Ball D. W., Compton D., Nelkin B. D., Baylin S. B. and de Bustros A. (1992) Human calcitonin gene regulation by helix-loop-helix recognition sequences. Nucleic Acids Res. 20, 117-123.
6. Bessis A., Champtiaux N., Chatelin L. and Changeux J. P. (1997) The neuron-restrictive silencer element: a dual enhancer/silencer crucial for patterned expression of a nicotinic receptor gene in the brain. Proc. Natl. Acad. Sci. USA 94, 5906-5911.
7. Bonini J. A., Jones K. A., Adham N., Forray C., Artymyshyn R., Durkin M. M., Smith K. E., Tamm. J. A., Boteju L. W., Lakhlani P. P., Raddatz R., Yao W. J., Ogozalek K. L., Boyle N., Kouranova E. V., Quan Y., Vaysse P. J., Wetzel J. M., Branchek T. A., Gerald C. and Borowsky B. (2000) Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J. Biol. Chem. 275, 39324-39331.
8. Brandt A., Pietilä, P., Nieminen M.-L. and Panula P. (2000) Neuropeptide FF in the mouse CNS: regional distribution and binding properties. Soc. Neurosci. Abstract 26, 18.2.
9. Carey M. and Smale S. T. (2000) Transcriptional Regulation in Eukaryotes, pp. 116-123. Cold Spring Harbor Laboratory Press, New York.
10. Coulson J. M., Fiskerstand C. E., Woll P. J. and Quinn J. P. (1999) E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer. Biochem. J. 344, 961-970.
11. Dong X., Han S., Zylka M. J., Simon M. I. and Anderson D. J. (2001) A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106, 619-632.
12. Elshourbagy N. A., Ames R. S., Fizgerald L. R., Foley J. J., Chamers J. K., Szekeres P. G., Evans N. A., Schmidt D. B., Buckley P. T., Dytko G. M., Murdock P. R., Tan K. B., Shabon U., Nuthulaganti P., Wang D. Y., Wilson S., Bergsma D. J. and Sarau H. M. (2000) Receptor for the pain modulatory neuropeptides NPFF and NPAF is an orphan G protein-coupled receptor. J. Biol. Chem. 275, 25965-25971.
13. Fink L., Seeger W., Ermert L., Hanze J., Stahl U., Grimminger F., Kummer W. and Bohle R. M. (1998) Real-time quantitative RTPCR after laser-assisted cell picking. Nat. Med. 4, 1329-1333.
14. Givogri M. I., Kampf K., Schonmann V. and Campagnoni A. T. (2000) Identification of a novel silencer that regulates the myelin basic protein gene in neural cells. Gene 252, 183-193.
15. Greene L. A. and Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424-2428.
16. Hamanoue M., Middleton G., Wyatt S., Jaffray E., Hay R. T. and Davies A. M. (1999) p75-mediated NF-κB activation enhances the survival response of developing sensory neurons to nerve growth factor. Mol. Cell. Neurosci. 14, 28-40.
17. Higuchi H., Nakano K. and Miki N. (1992) Identification of NGF-response element in the rat neuropeptide Y gene and induction of the binding proteins. Biochem. Biophys. Res. Commun. 189, 1553-1560.
18. Hinuma S., Habata Y., Fujii R., Kawamata Y., Hosoya M., Fukusumi S., Kitada C., Masuo Y., Asano T., Matsumoto H., Sekiguchi M., Kurokawa T., Nishimura O., Onda H. and Fujino M. (1998) A prolactin-releasing peptide in the brain. Nature 393, 272-276.
19. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., Fujii R., Watanabe T., Kikuchi K., Terao Y., Yano T., Yamamoto T., Kawamata Y., Habata Y., Asada M., Kitada C., Kurokawa T., Onda H., Nishimura O., Tanaka M., Ibata Y. and Fujino M. (2000) New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat. Cell. Biol. 2, 703-708.
20. Kontinen V. K., Aarnisalo A. A., Idänpään-Heikkilä J. J., Panula P. and Kalso E. (1997) Neuropeptide FF in the rat spinal cord during carrageenan inflammation. Peptides 18, 287-292.
21. Kotani M., Mollereau C., Detheux M., Le Poul E., Brezillon S., Vakili J., Mazarguil H., Vassart G., Zajac J. M. and Parmentier M. (2001) Functional characterization of a human receptor for neuropeptide FF and related peptides. Br. J. Pharmacol. 133, 138-144.
22. Lecron J. C., Minault M., Allard M., Goube de Laforest P., Gombert J. and Simonnet G. (1992) Modulation of human lymphocyte proliferation by FLFQPQRFamide, a FMRFamide-like peptide with anti-opiate properties. J. Neuroimmunol. 38, 1-8.
23. Lee J. H., Miele M. E., Hicks D. J., Phillips K. K., Trent J. M., Weissman B. E. and Welch D. R. (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl. Cancer Inst. 88, 1731-1737. [Erratum in. J. Natl. Cancer Inst 89, 1549]
24. Li B. S., Kramer P. R., Zhao W., Ma W., Stenger D. A. and Zhang L. (2000) Molecular cloning, expression, and characterization of rat homolog of human AP-2α that stimulates neuropeptide Y transcription activity in response to nerve growth factor. Mol. Endocrinol. 14, 837-847.
25. Li L., Suzuki T., Mori N. and Greengard P. (1993) Identification of a functional silencer element involved in neuron-specific expression of the synapsin I gene. Proc. Natl. Acad. Sci. USA 90, 1460-1464.
26. Liu D. and Fischer I. (1996) Two alternative promoters direct neuron-specific expression of the rat microtubule-associated protein 1B gene. J. Neurosci. 16, 5026-5036.
27. Liu Q., Guan X. M., Martin W. J., McDonald T. P., Clements M. K., Jiang Q., Zeng Z., Jacobson M., Williams D. L., Yu H., Jr Bomford D., Figueroa D., Mallee J., Wang R., Evans J., Gould R. and Austin C. P. (2001) Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J. Biol. Chem. 276, 36961-36969.
28. Maggirwar S. B., Sarmiere P. D., Dewhurst S. and Freeman R. S. (1998) Nerve growth factor-dependent activation of NF-κB contributes to survival of sympathetic neurons. J. Neurosci. 18, 10356-10365.
29. Majane E. A. and Yang H.-Y. T. (1987) Distribution and characterization of two putative endogenous antagonist peptides in bovine brain. Peptides 8, 657-662.
30. 2-like peptide in rat pituitary: decrease by osmotic stimulus. Peptides 12, 1303-1308.
31. 2). Endocrinology 133, 1578-1584.
32. 2-like mammalian peptide precipitates opiate withdrawal syndrome in the rat. Peptides 11, 277-280.
33. Mandel G. and McKinnon D. (1993) Molecular basis of neural-specific gene expression. Annu. Rev. Neurosci. 16, 323-345.
34. Minault M., Lecron J. C., Labrouche S., Simonnet G. and Gombert J. (1995) Characterization of binding sites for neuropeptide FF on T lymphocytes of the Jurkat cell line. Peptides 16, 105-111.
35. Minth-Worby C. A. (1994) Transcriptional regulation of the human neuropeptide Y gene by nerve growth factor. J. Biol. Chem. 269, 15460-15468.
36. Mori N., Schoenherr C., Vandenbergh D. J. and Anderson D. J. (1992) A common silencer element in the SCG10 and type II Na+ channel genes binds a factorpresent in nonneuronal cells but not in neuronal cells. Neuron 9, 45-54.
37. Myers S. J., Peters J., Huang Y., Comer M. B., Barthel F. and Dingledine R. (1998) Transcriptional regulation of the GluR2 gene: neural-specific expression, multiple promoters, and regulatory elements. J. Neurosci. 18, 6723-6739.
38. Nieminen M.-L., Brandt A., Pietilä P. and Panula P. (2000) Expression of mammalian RF-amide peptides neuropeptide FF (NPFF), prolactin-releasing peptide (PrRP) and the PrRP receptor in the peripheral tissues of the rat. Peptides 21, 1695-1701.
39. Panula P., Aarnisalo A. A. and Wasowicz K. (1996) Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog. Neurobiol. 48, 461-487.
40. Panula P., Kalso E., Nieminen M.-L., Kontinen V., Brandt A. and Pertovaara A. (1999) Neuropeptide FF and modulation of pain. Brain Res. 848, 191-196.
41. Panula P., Kivipelto L., Nieminen O., Majane E. A. and Yang H. Y. (1987) Neuroanatomy of morphine-modulating peptides. Med. Biol. 65, 127-135.
42. Paterson J. M., Mendelson S. C., McAllister J., Morrison C. F., Dobson S., Grace C. and Quinn J. P. (1995) Three immediate early gene response elements in the proximal preprotachykinin-A promoter in two functionally distinct domains. Neuroscience 66, 921-932.
43. Pathak B. G., Neumann J. C., Croyle M. L. and Lingrel J. B. (1994) The presence of both negative and positive elements in the 5′-flanking sequence of the rat Na,K-ATPase α 3 subunit gene are required for brain expression in transgenic mice. Nucl Acids Res. 22, 4748-4755.
44. Perry S. J., Yi-Kung H. E., Cronk C., Bagust J., Sharma R., Walker R. J., Wilson S. and Burke J. F. (1997) A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett. 409, 426-430.
45. Pertovaara A., Hämäläinen M. M., Kauppila T. and Panula P. (1998) Carrageenan-induced changes in spinal nociception and its modulation by the brain stem. Neuroreport 9, 351-355.
46. Quinn J. P. (1996) Neuronal-specific gene expression: the interactions of both positive and negative transcriptional regulators. Prog. Neurobiol. 50, 363-379.
47. 2 antiserum. Neuropeptides 10, 37-42.
48. Roumy M. and Zajac J. M. (1998) Neuropeptide FF, pain and analgesia. Eur J. Pharmacol. 345, 1-11.
49. Sakurai T., Moriguchi T., Furuya K., Kajiwara N., Nakamura T., Yanagisawa M. and Goto K. (1999) Structure and function of human prepro-orexin gene. J. Biol. Chem. 274, 17771-17776.
50. Seth K. A. and Majzoub J. A. (2001) Repressor element silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) can act as an enhancer as well as a repressor of corticotropin-releasing hormone gene transcription. J. Biol. Chem. 276, 13917-13923.
51. Smale S. T. (1997) Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim. Biophys. Acta 1351, 73-88.
52. Sundblom M., Panula P. and Fyhrqvist F. (1995) Neuropeptide FF in human plasma. Peptides 16, 347-350.
53. Therrien M. and Drouin J. (1993) Molecular determinants for cell specificity and glucocorticoid repression of the proopiomelanocortin gene. Ann. NY Acad. Sci. 680, 663-671.
54. Timmusk T, Palm K., Metsis M., Reintam T., Paalme V., Saarma M. and Persson H. (1993) Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10, 475-489.
55. Vilim F. S., Aarnisalo A. A., Nieminen M.-L., Lintunen M., Karlstedt K., Kontinen V. K., Kalso E., States B., Panula P. and Ziff E. (1999) Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol. Pharmacol. 55, 804-811.
56. Wei H., Panula P. and Pertovaara A. (1998) A differential modulation of allodynia, hyperalgesia and nociception by neuropeptide FF in the periaqueductal gray of neuropathic rats: interactions with morphine and naloxone. Neuroscience 86, 311-319.
57. Wood J. N. (1995) Regulation of NF-kappa B activity in rat dorsal root ganglia and PC12 cells by tumour necrosis factor and nerve growth factor. Neurosci. Lett. 192, 41-44.
58. Yamada M., Ozawa A., Ishii S., Shibusawa N., Hashida T., Ishizuka T., Hosoya T., Monden T., Satoh T. and Mori M. (2001) Isolation and characterization of the rat prolactin-releasing peptide gene: multiple TATA boxes in the promoter region. Biochem. Biophys. Res. Commun. 281, 53-56.
59. Yang H.-Y. T., Fratta W., Majane E. A. and Costa E. (1985) Isolation, sequencing, synthesis and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. USA 82, 7757-7761.
60. Yoon S. O., Casaccia-Bonnefil P., Carter B. and Chao M. V. (1998) Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J. Neurosci. 18, 3273-3281.